1. Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study
by Andreas K. Øvlisen, Anders Oest, Mette D. Bendtsen, John Bæch, Preben Johansen, Line S. Lynggaard, Ingolf Mølle, Thomas B. Mortensen, Duruta Weber, Gideon Ertner, Claudia Schöllkopf, Jesper Q. Thomassen, Ove Juul Nielsen, Lene Sofie Granfeldt Østgård, Martin Bøgsted, Karen Dybkær, Hans E. Johnsen, and Marianne T. Severinsen
BloodAdv
Volume 2(5):
March 13, 2018
© 2018 by The American Society of Hematology

2. Andreas K. Øvlisen et al. Blood Adv 2018;2:559-564
© 2018 by The American Society of Hematology

3. The patient cohort and defined study population.
The patient cohort and defined study population. Flowchart describing the postinduction, classical CR cohort and final study population. In total, 832 patients met all inclusion criteria. Because of missing data regarding blood samples in LABKA and patients’ transfusion history, the final study population included 769 patients who were included in the population analyzed in the present study. APL, acute promyelocytic leukemia.
Andreas K. Øvlisen et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology

4. Absolute and relative numbers of patients with insufficient 3-lineage recovery.
Absolute and relative numbers of patients with insufficient 3-lineage recovery. Venn diagram illustrating analysis of international consensus criteria for CR in patients who did not fulfill sCR criteria (non-sCR patients).
Andreas K. Øvlisen et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology

5. OS and RFS. Kaplan-Meier estimates for OS (A) and RFS (B) presented with 95% CIs and log-rank test for 769 patients at risk.
OS and RFS. Kaplan-Meier estimates for OS (A) and RFS (B) presented with 95% CIs and log-rank test for 769 patients at risk. (A) Probability of OS in patients who achieved sCR or non-sCR. (B) Probability of RFS of patients who achieved sCR or non-sCR.
Andreas K. Øvlisen et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology